Junshi Biosciences Announces Inclusion of Toripalimab in The China National Reimbursement Drug List

NEXT STORY
Changes to the Nomination Committee for Immunicum AB (publ)
PREV STORY
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ziopharm Oncology to Host Conference Call to Discuss Second Quarter 2019 Results on August 8, 2019

author_avatar
NASDAQ Market News

Merus Announces $55.8 Million Private Placement Offering of Common Stock

UTRECHT, The Netherlands, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.

FIT Biotech Oy                                                                                               Press Release July 3rd 2018, 08.30 EET FIT Biotech webcasts the ...

author_avatar
NASDAQ Market News